J. Scott Wolchko, President and CEO at FATE THERAPEUTICS INC (FATE), sold 40,000 shares at $101.42 ($4.1M) on 2021-02-18, disclosed to the SEC on 2021-02-19.
Open-market sale of $4.1M FATE by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $99.08 | 1,401 | $139K | 3.4% |
| 2 | $99.08 | 1,401 | $139K | 3.4% |
| 3 | $100.48 | 1,848 | $186K | 4.6% |
| 4 | $100.48 | 1,848 | $186K | 4.6% |
| 5 | $101.42 | 2,602 | $264K | 6.5% |
| 6 | $101.42 | 2,602 |
| $264K |
| 6.5% |
| 7 | $102.26 | 8,602 | $880K | 21.6% |
| 8 | $102.26 | 8,602 | $880K | 21.6% |
| 9 | $103.16 | 5,547 | $572K | 14.0% |
| 10 | $103.16 | 5,547 | $572K | 14.0% |
| Total | $102.01 avg | 40,000 | $4.1M | 100% |
| Filing → |
| FATE | SELL | 2022-07-25 | $2.4M | — | Filing → |
| FATE | SELL | 2022-04-25 | $2.6M | — | Filing → |
| FATE | SELL | 2022-01-24 | $2.0M | — | Filing → |